Sign in

CIK 0001768224

  • Accelerated filer
  • Smaller reporting company

Arcturus Therapeutics Holdings Inc.

Sign in to watch
Ticker
ARCT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 858-900-2660
Business address
10285 SCIENCE CENTER DRIVE, SAN DIEGO, CA
  1. 4 Planned sale Chief Scientific Officer & COO sold 8,565 shares at $35.01 ($299,839)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Planned sale Chief Scientific Officer & COO sold 5,000 shares at $18.72 ($93,602)
  8. 4 Planned sale Chief Scientific Officer & COO sold 5,000 shares at $25.61 ($128,062)
  9. 4 Planned sale Chief Scientific Officer & COO sold 5,000 shares at $31.45 ($157,264)
  10. 4 Grant or award Chief Financial Officer acquired 1,223 shares (grant or award)
  11. 4 Planned sale Chief Scientific Officer & COO sold 5,000 shares at $34.91 ($174,550)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Planned sale Chief Scientific Officer & COO sold 25,000 shares at $35.01 ($875,250)
  19. 4 Open-market sale See Remarks sold 6,968 shares at $35.00 ($243,880)
  20. 4 Planned sale Chief Scientific Officer & COO sold 5,000 shares at $28.75 ($143,750)

Page 3 of 8 · 149 filings